Pantoprazole, aFDA-approved proton-pump inhibitor, suppresses colorectal cancer growth bytargeting T-cell-originated protein kinase.
Pantoprazole, aFDA-approved proton-pump inhibitor, suppresses colorectal cancer growth bytargeting T-cell-originated protein kinase.
复制标题
泮托拉唑是 FDA 批准的质子泵抑制剂，通过靶向 T 细胞来源的蛋白激酶来抑制结直肠癌的生长。
作者：
Xiaoyu Zeng;Lin Liu;Mengzhu Zheng;Huimin Sun;Juanjuan Xiao;Tao Lu;Guangqian Huang;Pianpian Chen;Jianmin Zhang;Feng Zhu;Hua Li;Qiuhong Duan
